What a Direct Listing is
A Direct Listing is, mechanically, a Covenant Phase 2 without the Phase 1 that usually precedes it. Ten thousand ERC-20 tokens mint at listing; each carries a -fraction of the issuer’s future TEB, where is a committed share rate between 1% and 5% and . Distributions flow quarterly. The token never expires.
The instrument suits people who aren’t raising capital but want price discovery, backer alignment, or eventually a liquidity event (established creators, post-exit founders, executive-track professionals, athletes) without giving up equity in any company.
Eligibility · the baseline gate
The review panel looks for four things:
| Criterion | Minimum | Why |
|---|---|---|
| Documented trajectory | 5+ years of attestable TEB (tax returns, W-2s, 1099s, K-1s) | Backward signals in the conviction model need 3+ years to be meaningful; 5 is comfortable margin |
| Conviction score | ≥ 65 | Higher threshold than covenants (60) because Direct Listings skip the covenant-period observation window |
| Income diversification | HHI ≤ 0.60 | Single-stream income earners are re-routed to covenants. Power-law concentration requires runway to evaluate. |
| Regulatory clearability | No active SEC / FINRA sanctions, no pending material litigation | Counsel-reviewed above $1M implied market cap |
Review process · 4 – 12 weeks
- 1.Application. Issuer submits attestable history, proposed , and narrative.
- 2.TEB reconstruction. Preflop reconstructs 5-year TEB from the issuer’s tax filings. Issuer attests.
- 3.Conviction scoring. Full 11-signal model with backward block weighted to 60%.
- 4.Cap-check. Against any existing covenants on the same issuer (see cross-listing math).
- 5.Counsel review. If implied market cap exceeds $1M, outside counsel sign-off on securities treatment under Reg D.
- 6.Decision. Accept, counter-offer (lower or adjusted terms), or reject with named deficiencies.
Lockup · 2 – 8 weeks
Accepted listings enter lockup before tokens transfer. Lockup length scales with implied market cap: 2 weeks for listings under $500K, up to 8 weeks at $5M+. The lockup serves two purposes: orderly price discovery when the book opens, and a final window for material-event disclosure before trading begins.
Pricing · Gordon anchor, same as Phase 2
Direct Listings price via the pure-perpetuity collapse of the general pricing integral, identical in form to a post-T Covenant Phase 2 token:
Worked reference
Direct Listing with , , , . at CI ±30%.
See the pricing spec for the four-stage lifecycle.
Why the DL is the canonical fractional-equity instrument
For a Direct Listing parameterized as , a single share rate over a window matching the integration window. The effective equity rate collapses exactly:
No approximation, no piecewise integration, no forecast-dependence in the ratio. A 2% Direct Listing is a 2% fractional claim on the issuer’s lifetime human capital, full stop.
This makes the DL the canonical fractional-equity instrument on Preflop. The cleanest mapping from share rate to ownership fraction. Covenants approximate this with their two-phase structure; DLs nail it directly.
Dr. Amara Okafor at listing · Gordon idealization
Constant-growth Gordon forecast: TEB(0) = $2M, through year 10, .
. DL at , so exact.
. Per token: . Reserve at the 80% / low-band convention: (using ≈ $17.85M).
Engine cross-reference (v2.1.0) —The Gordon idealization above (constant 3% growth then 2% terminal, single-stage closed form) illustrates the eeff = e collapse identity. The production Forecast Engine v2.1.0 runs the same Amara inputs through the medicine-surgical-private cohort (gaussian shape, quarters) with 5 years of personal historicalTEB → , 6 of 15 adjustments fire (β ≈ 0.25), and produces a 5-segment piecewise growth schedule. Engine output: , per-token mid (low , high , CI 120%). The ~0.8% drift between the closed-form $21.32M and the engine’s $21.49M is intentional: established issuers with substantial personal data converge across forecast paths. See forecast-engine §Amara for the full piecewise walkthrough.
See the human-capital spec for the VHC and eeff identity, and the raise-mechanism spec for how the auction clears around the published reserve.
Cross-listing with existing covenants
A Direct Listing on an issuer who already has a Covenant must satisfy the 25% TEB cap invariant at every point in time. The cap-check runs both algorithms from the cross-listing math spec before the listing is approved.
Worked cross-listing
Issuer has a s=5%, T=7, ecov=2% covenant at year 3. New Direct Listing at edir=3%.
Years 3–7 total utilization: 5% + 3% = 8%. Years 7+: 2% + 3% = 5%. Under 25% at every point → accepted. The two listings trade independently; at year 7, covenant tokens transition to Phase 2 and become economically equivalent to the Direct Listing class.
Direct Listing vs. Covenant · which is which
| Dimension | Covenant | Direct Listing |
|---|---|---|
| Capital at listing | Yes (principal R) | No (Flow A default). Flow C = deferred liquidity on reserved block. |
| Best for | Pre-seed founders; early-career creators | 5+ year documented trajectory; post-exit founders, established creators |
| Phase 1 dividend stream? | Yes (years 1 – T) | No |
| Phase 2 perpetuity? | Yes (year T+) | Yes (day 1) |
| Review length | 2 – 4 weeks | 4 – 12 weeks |
| Lockup | Multiple triggers (data + conviction + funding) | Fixed 2 – 8 weeks |
| Conviction gate | ≥ 60 | ≥ 65 |